Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous tranexamic acid for scar formation after abdominoplasty or bilateral mammoplasty
IRCT20250820066933N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in severe cutaneous adverse reactions (SCAR) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Overall scar effect based on Vancouver Scar Scale, Scar vascularity and 3 more. Started Nov 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
severe cutaneous adverse reactions (SCAR)
Beyond the preview
Go deeper on IRCT20250820066933N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250820066933N1.